Nexalin Technology, Inc.
NXL • NASDAQ
Nexalin Technology, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Mark White, with a market cap of $7.5M.
CEOMark White
Next Earnings
Upcoming earnings announcement for Nexalin Technology, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
Time TBD (3:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.12
Revenue Estimate
$100.0K
Earnings History
Past 12 earnings reports for Nexalin Technology, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.13Est: -$0.12 | -8.3% | $171.9KEst: $80.0K | +114.9% | — |
| Nov 14, 2025 | Q3 2025 | -$0.13Est: -$0.12 | -8.3% | $18.1KEst: $40.0K | -54.6% |  10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.10Est: -$0.14 | +28.6% | $70.6KEst: $35.0K | +101.7% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.15Est: -$0.10 | -50.0% | $41.0KEst: $35.0K | +17.2% | 10-Q |
| Mar 14, 2025 | Q4 2024 | -$0.28Est: -$0.12 | -133.3% | $27.2KEst: $30.0K | -9.4% | 10-K/A |
| Nov 8, 2024 | Q3 2024 | -$0.23 | — | $36.0K | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.17 | — | $26.8K | — | 10-Q |
| May 10, 2024 | Q1 2024 | -$0.14 | — | $78.7K | — | 10-Q |
| Mar 27, 2024 | Q4 2023 | -$0.10 | — | $20.5K | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.31 | — | $24.1K | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.11 | — | $35.5K | — | — |
| May 10, 2023 | Q1 2023 | -$0.10 | — | $30.6K | — | — |